pharma · Multiple System Atrophy · ATHE
ALTERITY THERAPEUTICS
ALTERITY THERAPEUTICS LTD
ALTERITY THERAPEUTICS patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Melbourne, AU HQ
15 Employees
Public company Type
ATHE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Employees
- 15
- Programs
- 3
- Drugs
- 1
- Patents
- 4
ALTERITY THERAPEUTICS patents
4 pharmaceutical patents indexed for ALTERITY THERAPEUTICS. 0 expire within 24 months.
ALTERITY THERAPEUTICS has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does ALTERITY THERAPEUTICS have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ALTERITY THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.